longbridgelongbridge
  • Products
  • Fees
  • Download
  • Promotions
    Welcome RewardsReferral ProgramUS Pre-Market Options Trading
  • For Institutions
    Corporate ServicesDevelopers
  • Help
  • About
    About LongbridgeLicense & RegulatoryMedia CoverageJoin Us
longbridge
  • Home
  • Discover
    Discover
    Global MarketsStock ScreenerFinancial Calendar
  • News & Info
    News & Info
    NewsInsightsLiveAcademy
  • Watchlist
  • Trade
  • Notification
  • LongbridgeAI
Home
Discover
News & Info
Watchlist
Trade
LongbridgeAI
Quote ListQuote List

Whitehawk Therapeutics(WHWK.US)

Last Updated 19:00:00 ET
longbridge loading
News
Financials
Overview

Whitehawk Therapeutics to Participate in the TD Cowen 7th Annual Oncology Innovation Summit | WHWK Stock News

StockTitan·18 Hours ago
US
WHWK
+3.69%
StockTitan·18 Hours ago
US
WHWK
+3.69%

Whitehawk Therapeutics to Participate in 2026 Stifel Virtual Targeted Oncology Forum | WHWK Stock News

StockTitan·05/15/2026 12:00
US
WHWK
+3.69%
StockTitan·05/15/2026 12:00
US
WHWK
+3.69%

12 Health Care Stocks Moving In Wednesday's Intraday Session

benzinga_article·05/14/2026 01:06
US
RVPH
-3.46%
US
REPL
+9.79%
US
MXCT
+2.88%
benzinga_article·05/14/2026 01:06
US
RVPH
-3.46%
US
REPL
+9.79%
US
MXCT
+2.88%

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

benzinga_article·05/13/2026 20:06
US
QUCY
+30.56%
US
SLS
+18.18%
US
SER
+5.59%
benzinga_article·05/13/2026 20:06
US
QUCY
+30.56%
US
SLS
+18.18%
US
SER
+5.59%

Whitehawk Therapeutics | 8-K: FY2026 Q1 Revenue: USD 0

Earnings Watch·05/07/2026 21:17
US
WHWK
+3.69%
Earnings Watch·05/07/2026 21:17
US
WHWK
+3.69%

Whitehawk Therapeutics Presents Comprehensive Preclinical Data Highlighting its Next-Generation ADC Portfolio at the AACR 2026 | WHWK Stock News

StockTitan·04/19/2026 22:00
US
WHWK
+3.69%
StockTitan·04/19/2026 22:00
US
WHWK
+3.69%
© 2026 Longbridge|Disclaimer

Event Tracking

May8
Whitehawk Therapeutics released FY2026 Q1 earnings on May 7 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -0.3205 (forecast USD -0.1233)
03:00
Mar13
Whitehawk Therapeutics released FY2025 Q4 earnings on March 12 (EST), actual revenue USD 0 (forecast USD 20 M), actual EPS USD -0.3359 (forecast USD -0.154)
03:00
Whitehawk Therapeutics released FY2025 Annual Earnings on March 12 (EST), actual revenue USD 7.145 M (forecast USD 27.12 M), actual EPS USD -0.3328 (forecast USD -0.2425)
03:00
Nov18
Whitehawk Therapeutics Reveals Its Antibody-Drug Conjugate Pipeline in Corporate Presentation
11:41
Nov7
Whitehawk Therapeutics released FY2025 Q3 earnings on November 6 (EST), actual revenue USD 0 (forecast USD 33.33 M), actual EPS USD -0.26 (forecast USD 0.0666)
04:00
Whitehawk Therapeutics released FY2025 9 Months Earnings on November 6 (EST), with actual revenue of USD 7.145 M and actual EPS of USD 0.8083
04:00

Schedules & Filings

Schedules
Filings
May7
Earning Release(EST)

FY2026 Q1 Earning Release (USD) Net Income -22.19 M, EPS -0.3205

Mar12
Earning Release(EST)

FY2025 Q4 Earning Release (USD) Net Income -23.25 M, EPS -0.3359

Nov6
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Net Income -17.75 M, EPS -0.26

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
OPTH
6.080
+2,485.03%
+5.845
HCWB
2.430
+129.25%
+1.370
SLXN
0.5298
+96.95%
+0.261
VIDA
4.150
+81.22%
+1.860
GCL
0.7445
+72.46%
+0.313
PHGE
0.5969
+59.60%
+0.223
MTVA
2.890
+53.72%
+1.010
MWC
7.150
+51.48%
+2.430
PETZ
1.150
+41.98%
+0.340
MLGO
5.360
+39.95%
+1.530
View More